30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Aslan Fred

Track

Insider profile

Aslan Fred's trades of Artiva Biotherapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-19 2026-05-19
S Sale
84,896 +11.7%
342.38
US$2,037,363 		84,896 +11.7% 342.38 US$2,037,363
2026-05-18 2026-05-18
PrS Proposed sale
40,795
368.82
US$1,515,426 		40,795 368.82 US$1,515,426
2025-12-15 2025-12-15
PrS Proposed sale
79,205
125.17
US$2,132,165 		79,205 125.17 US$2,132,165
2025-12-15 2025-12-15
PlS Planned sale
3,187 -0.3%
6.00
US$19,122 		3,187 -0.3% 6.00 US$19,122
2025-11-17 2025-11-17
PrS Proposed sale
6,375
3.25
US$20,719 		6,375 3.25 US$20,719
2025-11-17 2025-11-17
PlS Planned sale
6,375 -1.8%
3.38
US$21,522 		6,375 -1.8% 3.38 US$21,522
2025-10-17 2025-10-17
PrS Proposed sale
25,500
2.77
US$70,635 		25,500 2.77 US$70,635
2025-10-17 2025-10-17
PlS Planned sale
25,500 -6.7%
6.00
US$153,000 		25,500 -6.7% 6.00 US$153,000
2025-08-18 2025-08-15
PlS Planned sale
25,500 -6.2%
2.73
US$69,579 		25,500 -6.2% 2.73 US$69,579
2025-08-15 2025-08-15
PrS Proposed sale
25,500
2.70
US$68,850 		25,500 2.70 US$68,850